Objectives

After participating in this educational activity, attendees should be able to:

1|Evaluate the impact of an antipsychotic stewardship team on Baystate Medical Center’s ACE unit
2|Describe the differences between Delirium and Dementia
3|Evaluate the effectiveness and safety of GLP-1 RAs for weight loss in community health settings
4|Review prescribing and titration patterns of semaglutide and liraglutide.
5|Explore barriers to treatment success, including follow-up and access issues
6|Evaluate the safety and efficacy of the new thymoglobulin dosing strategy
7|Develop a monitoring plan post-transplant for new and old dosing strategies
8|Evaluate the impact of CGM versus fingerstick monitoring on HbA1C levels in patients with T2DM in a primary care population
9|Evaluate the role of clinical pharmacists in supporting improved glycemic outcomes with CGM use
10|Describe data to inform clinical decisions regarding the integration of CGMs into standard diabetes management protocols
11|Describe the challenges associated with the hematology/oncology preadmission process at Baystate Medical Center
12| Outline the structure and implementation of a pharmacist-led preadmission review pilot program
13| Evaluate the impact of pharmacist involvement on formulary adherence, site-of-care optimization, and potential cost savings

 

Presenter(s): 

Brittney Brzoska, PharmD
PGY1 Pharmacy Resident 
Baystate Medical Center
 
Damaris Fuentes, PharmD
PGY1 Community Based Pharmacy Resident 
Baystate Medical Center
 
Huong (Ellie) Trinh, PharmD
PGY1 Pharmacy Resident 
Baystate Medical Center
 
Kathryn Higgins, PharmD
PGY1 Community Based Pharmacy Resident 
Baystate Medical Center
 
Tasneem Baker, PharmD
PGY1 Pharmacy Resident 
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Brittney Brzoska, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to disclose

No

Damaris Fuentes, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to disclose

No

Huong (Ellie) Trinh, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to disclose

No

Kathryn Higgins, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to disclose

No

Tasneem Baker, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to disclose

No

Session date: 
06/02/2025 - 2:00pm to 3:00pm EDT
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.